Literature DB >> 6192200

Growth of Streptococcus pyogenes and streptolysin O production in complex and synthetic media.

B Dassy, J E Alouf.   

Abstract

A comparative study of the growth of a highly haemolytic group A streptococcal strain in Trypticase-yeast extract medium and in a chemically defined medium was undertaken. Appreciable growth was obtained in the latter medium with the release of significant amounts (120 haemolytic units) of streptolysin O. This indicates that toxinogenic factors present only in the peptones of complex media are not essential for biosynthesis and release of this cytolytic toxin, as is the case for many bacterial toxins. NADase was also released in the synthetic medium. Bacterial cell mass, growth rate, and streptolysin O production were threefold higher in the complex medium. The effects of various carbohydrates on streptolysin O production in complex medium are investigated. No repression of toxin formation by glucose was observed. The relationship between growth and toxinogenesis in streptococci and in other toxinogenic bacteria is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192200     DOI: 10.1099/00221287-129-3-643

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  3 in total

1.  Persistence of Streptococcus pyogenes in stationary-phase cultures.

Authors:  Daniel N Wood; Michelle A Chaussee; Michael S Chaussee; Bettina A Buttaro
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

2.  Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein.

Authors:  B A Degnan; M C Fontaine; A H Doebereiner; J J Lee; P Mastroeni; G Dougan; J A Goodacre; M A Kehoe
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  The phosphoenolpyruvate phosphotransferase system in group A Streptococcus acts to reduce streptolysin S activity and lesion severity during soft tissue infection.

Authors:  Kanika Gera; Tuquynh Le; Rebecca Jamin; Zehava Eichenbaum; Kevin S McIver
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.